A cost controller’s take on buying Invacare equipment for long-term care, why value beats price, and when patient monitors and surgical laser systems don’t belong in the same purchase decision.

A cost controller’s take on buying Invacare equipment for long-term care, why value beats price, and when patient monitors and surgical laser systems don’t belong in the same purchase decision.

This isn’t one of those “you should always buy X” articles. Whether Invacare ends up in your cart depends on what you’re buying, who has to use it, and what the total cost looks like over five years—not just the number on the purchase order.

I’ve been managing procurement for a multi-site long-term care and rehab operation for about six years. Our annual equipment budget runs roughly $350,000 across seven buildings. I’ve negotiated with more vendors than I can count, and I’ve made enough mistakes to know where the real costs hide. The biggest one: treating every piece of equipment like the same kind of purchase.

The first thing I tell anyone who asks about Invacare is that the company makes some of the most reliable continuing care equipment I’ve had in our buildings. But the harder decision is when not to buy it. There are three distinct scenarios, and each one needs its own reasoning.

The Procurement Mistake That Costs More Than a Bad Price

Early on, I almost went with a lower-priced bed vendor because the upfront price was 18% less than the Invacare beds we’d standardized on. The numbers said switch. My gut said don’t. My gut wasn’t wrong: the rails didn’t fit the bed frames we already had, the staff had no training on the locking mechanism, and we ended up paying $3,100 for a retrofit and overtime labor.

The cheapest option gets expensive fast. But the same reasoning doesn’t mean you should buy Invacare for everything. That’s the nuance.

Scenario #1: When You’re Buying Inside Invacare’s Wheelhouse

For daily mobility, transfer, respiratory, and long-term care equipment—manual and power wheelchairs, hospital beds, patient lifts, oxygen concentrators—Invacare is a serious option. I call this the “continuing care ecosystem.” If your purchase lives in that ecosystem, the question isn’t just price; it’s cleanability, repair access, and staff familiarity.

Take the Invacare Perfecto2 oxygen concentrator. If someone in your building searches for the “invacare perfecto2 oxygen concentrator manual pdf,” Invacare publishes the manual on its website (invacare.com/manuals) as a downloadable PDF. That’s useful, but the manual isn’t the hard part. The hard part is the first training session. A concentrator that sits for two days because no one knows how to set the oxygen flow rate correctly isn’t a $900 device—it’s a $900 paperweight and a delay in patient care.

The Invacare hospital bed rail assembly is another example. The printed procedure looks simple enough, but a new staff member once installed a rail incorrectly and then had to strip the whole side of the bed to fix it. A trained biomed tech could do the job in 20 minutes. The cost is not the rail. The cost is the time, the disruption, and the safety review afterward.

What is infection control in this context? Per the CDC’s infection control guidelines (cdc.gov), it’s the set of practices to prevent the spread of infection. In purchasing terms, it means cleaner design and training. When I compare beds, I ask how long it takes to clean the rail assembly, the mattress cover, and the gaps in the frame. A little extra upfront price often buys fewer sanitizing barriers and less labor hours.

This is also where I’ve learned to look at cost per room, not cost per bed. A bed that costs $250 more but takes five minutes less to clean adds up. If housekeeping touches that bed twice a day, that’s roughly 60 hours over two years. At $18 an hour, the “expensive” bed just paid for itself. That kind of math is rarely on the quote.

Scenario #2: When Standardization Is the Point

Now imagine you already have a fleet of Invacare beds, lifts, and wheelchairs across multiple units. Your nursing staff knows where the rail releases are. Your biomed team has the tools and parts. Your maintenance inventory already has the brake levers and casters.

In that case, sticking with Invacare can be the cost-conscious move even when another brand’s bid is lower. Not because Invacare is magical, but because the switching cost is real. Training, spare parts, and troubleshooting all have a price tag. To be fair, if you’re a new facility with no existing inventory, you can choose any brand and build the ecosystem from scratch. But if you already have an ecosystem, a 6% price difference can easily disappear in the second year when you’re cross-training nurses and writing new service contracts.

This is the decision point where I used to regret my own bias. I still kick myself for not documenting why we chose a different ventilator manufacturer back in 2021. The lower initial quote looked great on paper, but the service rep was two hours away and the replacement parts were out of stock half the year. It took three years to undo the fragmentation. Now, when I look at an Invacare quote, I compare my own maintenance history with that brand, not just the price.

I built a simple TCO spreadsheet after that experience. For each equipment model, I track purchase price, estimated installation time, annual maintenance, and expected lifespan. It’s not fancy, but it keeps me from making decisions on sticker price alone. If I’m honest, the spreadsheet is what caught the $3,100 retrofit problem in the bed purchase—I just ignored it because I wanted the cheaper option to work.

Scenario #3: When the Answer Is Not Invacare

There’s a third scenario, and this one is just as important: when you’re buying something outside the continuing care world. A patient monitor is a perfect example. It has to link with your electronic medical record, central monitoring station, and nurse call system. That integration workflow is not something a mobility and bed supply company is set up to support. When a department asks for a patient monitor, I start with vendors whose primary business is patient monitoring. That’s not a criticism of Invacare—it’s scope discipline.

Same with a laser surgery system. The surgical laser has different regulatory requirements, disposable components, service contracts, and clinical training paths. It doesn’t make sense to route that purchase through your long-term care vendor. Once, a facility I know tried to bundle a laser surgery system into a broader equipment quote to simplify procurement. The result was a two-month delay because the sales rep didn’t know the first thing about laser delivery systems. We ended up canceling that part of the order and going through a dedicated surgical distributor.

This is where “value over price” gets interesting. The highest-value move is not to be loyal to one catalog. It’s to be loyal to solving the clinical problem efficiently. If a device needs integration or surgical-grade support, buy from the specialist. If it needs durable, cleanable, familiar patient-use equipment, buy from a continuing care specialist.

A patient monitor might look like a simple screen, but the cost of integrating a new network of monitors into an existing infrastructure can be more than the hardware itself. The same goes for a surgical laser: the training cost for your OR team is part of the purchase. A $20,000 laser that requires $8,000 in credentialing and oversight is not a $20,000 line item.

How to Tell Which Scenario You’re In

I’ve built a simple decision shortcut for my own team. Ask three questions:

  • Is this device used by patients for mobility, transfer, respiratory therapy, or daily care in a post-acute setting? If yes, you’re in Scenario #1 or #2.
  • Do you already operate a standardized fleet of Invacare equipment in this area? If yes, Scenario #2 applies—only switch if the total cost gap is large enough to cover retraining and inventory changes.
  • Is this purchase part of a wider integrated system, like patient monitoring or surgical lasers? If yes, stop looking at long-term care catalogs. Buy from a specialist.

That last one is probably the counterintuitive one. A lot of procurement thinking, including my earlier years, assumes consistency across a vendor relationship. In reality, the highest-value approach can look inconsistent: standardize deeply within each clinical product category, but don’t standardize across categories that have nothing in common.

I’m not going to give you a “one simple trick” ending. The right purchase depends on your current fleet, your staff, and what you’ll have to live with after the invoice is paid. But the best procurement decisions I’ve made were the ones where I stopped asking “what’s the brand?” and started asking “what’s the total cost of caring for this device in this setting?”

As of January 2025, the Invacare manual library (invacare.com/manuals) remains the best source for verifying current instructions and part numbers. Always double-check the specific model number and consult your own biomed team before making a final call.


Samuel Okafor

Samuel Okafor

Samuel Okafor is an in-vitro diagnostics and clinical laboratory equipment analyst covering chemistry and hematology analyzers, immunoassay systems, PCR platforms, centrifuges, and electronic pipettes. He applies IEC 61010-2-101 and examines analytical sensitivity, precision, carryover, calibration traceability, sample throughput, reagent stability, reportable range, and operator maintenance requirements. His guides help laboratory directors, clinical scientists, quality teams, and buyers evaluate assay performance, biosafety, automation capacity, consumable dependence, and total workflow cost.